HRTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.76%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Heron Therapeutics Insider Trading History Chart

Heron Therapeutics Share Price & Price History

^$2.11

▼ -0.09 (-4.09%)

As of 04/1/2025 05:00 PM ET

Days: 30 | 90 | 365

Heron Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/16/2023	Craig A Collard	CEO	Buy	150,000	$0.92	$138,000.00	186,496
11/16/2023	Ira Duarte	CFO	Buy	85,000	$0.89	$75,650.00	85,000
11/16/2023	William P Forbes	EVP	Buy	50,000	$0.94	$47,000.00	54,000
7/21/2023	Adam Morgan	Director	Buy	2,486,744	$1.37	$3,406,839.28	6,986,744
5/3/2022	Kimberly Manhard	EVP	Sell	1,504	$4.76	$7,159.04	10,872

SEC Filings (Institutional Ownership Changes) for Heron Therapeutics (NASDAQ:HRTX)

80.01% of Heron Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Heron Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/24/2025	Wellington Management Group LLP	488,122	$0.75M	0.0%	-1.6%	0.320%
3/17/2025	Wealth Enhancement Advisory Services LLC	35,134	$54K	0.0%	-22.4%	0.023%
2/27/2025	Carolinas Wealth Consulting LLC	41,356	$63K	0.0%	+49.4%	0.027%
2/17/2025	Two Sigma Advisers LP	823,871	$1.26M	0.0%	+1.5%	0.542%
2/17/2025	Two Sigma Investments LP	990,169	$1.52M	0.0%	-29.4%	0.651%
2/17/2025	State of Wyoming	29,736	$45K	0.0%	+573.5%	0.020%
2/17/2025	Stonepine Capital Management LLC	700,000	$1.07M	0.9%	N/A	0.460%
2/17/2025	Tang Capital Management LLC	2,140,271	$3.28M	0.2%	+15.7%	1.407%
2/17/2025	Point72 Asset Management L.P.	3,075,809	$4.71M	0.0%	N/A	2.022%
2/17/2025	ProShare Advisors LLC	33,063	$51K	0.0%	+49.0%	0.022%
2/17/2025	Nuveen Asset Management LLC	314,275	$0.48M	0.0%	-71.6%	0.207%
2/17/2025	Millennium Management LLC	215,531	$0.33M	0.0%	-76.9%	0.142%
2/17/2025	J. Goldman & Co LP	270,100	$0.41M	0.0%	N/A	0.178%
2/17/2025	Focus Partners Wealth	20,000	$31K	0.0%	N/A	0.013%
2/17/2025	Clearline Capital LP	1,810,483	$2.77M	0.4%	-18.7%	1.190%
2/17/2025	D. E. Shaw & Co. Inc.	3,723,706	$5.70M	0.0%	-15.1%	2.448%
2/17/2025	Cornerstone Select Advisors LLC	50,755	$78K	0.1%	N/A	0.033%
2/17/2025	Bridgeway Capital Management LLC	300,000	$0.46M	0.0%	N/A	0.197%
2/17/2025	Bank of America Corp DE	1,046,790	$1.60M	0.0%	+9.5%	0.688%
2/14/2025	Jane Street Group LLC	47,827	$73K	0.0%	-85.6%	0.031%
2/14/2025	Northern Trust Corp	1,011,756	$1.55M	0.0%	+2.2%	0.665%
2/14/2025	Integrated Wealth Concepts LLC	111,083	$0.17M	0.0%	+127.7%	0.073%
2/14/2025	Adage Capital Partners GP L.L.C.	8,500,000	$13.01M	0.0%	-4.0%	5.588%
2/14/2025	Price T Rowe Associates Inc. MD	46,179	$71K	0.0%	+23.2%	0.030%
2/13/2025	Marshall Wace LLP	1,017,539	$1.56M	0.0%	-40.7%	0.669%
2/13/2025	Barclays PLC	241,346	$0.37M	0.0%	+10.5%	0.159%
2/13/2025	Quinn Opportunity Partners LLC	380,000	$0.58M	0.0%	N/A	0.250%
2/13/2025	Raymond James Financial Inc.	135,722	$0.21M	0.0%	N/A	0.089%
2/13/2025	Renaissance Technologies LLC	1,188,800	$1.82M	0.0%	-40.8%	0.782%
2/13/2025	Invesco Ltd.	71,399	$0.11M	0.0%	+38.2%	0.047%
2/13/2025	Aristides Capital LLC	52,849	$81K	0.0%	N/A	0.035%
2/13/2025	Envestnet Asset Management Inc.	17,748	$27K	0.0%	-36.3%	0.012%
2/13/2025	Wells Fargo & Company MN	74,763	$0.11M	0.0%	+22.2%	0.049%
2/12/2025	Nicolet Advisory Services LLC	16,000	$25K	0.0%	N/A	0.011%
2/12/2025	Biltmore Family Office LLC	101,467	$0.16M	0.0%	N/A	0.067%
2/12/2025	Geode Capital Management LLC	3,015,327	$4.62M	0.0%	-1.0%	1.982%
2/12/2025	Headlands Technologies LLC	25,672	$39K	0.0%	-48.3%	0.017%
2/12/2025	Wellington Management Group LLP	488,122	$0.75M	0.0%	-1.6%	0.321%
2/12/2025	JPMorgan Chase & Co.	562,764	$0.86M	0.0%	+172.2%	0.370%
2/11/2025	LPL Financial LLC	58,098	$89K	0.0%	-11.5%	0.038%
2/11/2025	Richmond Brothers Inc.	642,339	$0.98M	0.6%	+25.8%	0.422%
2/11/2025	Intech Investment Management LLC	58,242	$89K	0.0%	+61.8%	0.038%
2/10/2025	Tejara Capital Ltd	4,661,547	$7.13M	4.6%	-12.1%	3.065%
2/10/2025	Argent Advisors Inc.	20,000	$31K	0.0%	N/A	0.013%
2/10/2025	Monaco Asset Management SAM	1,212,743	$1.86M	0.3%	-27.7%	0.797%
2/7/2025	CM Management LLC	700,000	$1.07M	0.9%	+40.0%	0.460%
2/6/2025	Raymond James Financial Inc.	135,722	$0.21M	0.0%	N/A	0.089%
2/6/2025	Charles Schwab Investment Management Inc.	1,105,803	$1.69M	0.0%	+0.9%	0.727%
2/5/2025	Anfield Capital Management LLC	118,976	$0.18M	0.1%	+5.6%	0.078%
2/5/2025	Motiv8 Investments LLC	69,245	$0.11M	0.1%	-10.8%	0.046%
2/4/2025	Cutter & CO Brokerage Inc.	33,135	$51K	0.0%	+69.6%	0.022%
2/4/2025	Los Angeles Capital Management LLC	67,653	$0.10M	0.0%	-69.4%	0.044%
1/31/2025	New York State Common Retirement Fund	1,321,006	$2.02M	0.0%	+3.2%	0.869%
1/31/2025	D.A. Davidson & CO.	37,000	$57K	0.0%	-82.7%	0.024%
1/31/2025	Principal Financial Group Inc.	113,560	$0.17M	0.0%	+10.6%	0.075%
1/17/2025	Apeiron RIA LLC	262,542	$0.40M	0.1%	+7.8%	0.173%
1/17/2025	Capital Planning Advisors LLC	106,565	$0.16M	0.0%	+41.0%	0.070%
1/15/2025	Arkadios Wealth Advisors	50,000	$76K	0.0%	N/A	0.033%
1/15/2025	Congress Park Capital LLC	2,455,495	$3.76M	1.4%	+24.1%	1.614%
12/26/2024	JPMorgan Chase & Co.	206,711	$0.41M	0.0%	+295.8%	0.136%
12/19/2024	Principal Financial Group Inc.	102,651	$0.20M	0.0%	+456.5%	0.067%
11/27/2024	Franklin Resources Inc.	23,026	$46K	0.0%	-99.6%	0.015%
11/19/2024	Barclays PLC	218,455	$0.43M	0.0%	+29.8%	0.144%
11/16/2024	Geode Capital Management LLC	3,045,361	$6.06M	0.0%	-2.2%	2.002%
11/15/2024	Barclays PLC	218,455	$0.43M	0.0%	+29.8%	0.144%
11/15/2024	Y Intercept Hong Kong Ltd	19,629	$39K	0.0%	N/A	0.013%
11/15/2024	XTX Topco Ltd	297,568	$0.59M	0.0%	+449.0%	0.196%
11/15/2024	Zacks Investment Management	475,575	$0.95M	0.0%	+2.4%	0.313%
11/15/2024	Jane Street Group LLC	332,126	$0.66M	0.0%	-5.4%	0.218%
11/15/2024	Wellington Management Group LLP	496,227	$0.99M	0.0%	-4.8%	0.326%
11/15/2024	State Street Corp	3,192,436	$6.35M	0.0%	-39.5%	2.099%
11/15/2024	Clearline Capital LP	2,226,512	$4.43M	0.2%	+48.9%	1.464%
11/14/2024	Verition Fund Management LLC	108,115	$0.22M	0.0%	+340.0%	0.071%
11/14/2024	Capstone Investment Advisors LLC	22,666	$45K	0.0%	N/A	0.015%
11/13/2024	Glenmede Trust Co. NA	31,903	$63K	0.0%	+49.6%	0.021%
11/13/2024	BNP Paribas Financial Markets	275,946	$0.55M	0.0%	+50.4%	0.182%
11/13/2024	FMR LLC	431,906	$0.86M	0.0%	+26.2%	0.285%
11/12/2024	Pekin Hardy Strauss Inc.	15,170	$30K	0.0%	-39.7%	0.010%
11/12/2024	Charles Schwab Investment Management Inc.	1,096,385	$2.18M	0.0%	-3.6%	0.723%
11/9/2024	Intech Investment Management LLC	35,988	$72K	0.0%	N/A	0.024%
11/6/2024	King Wealth Management Group	23,299	$46K	0.0%	+52.3%	0.015%
11/5/2024	GSA Capital Partners LLP	512,736	$1.02M	0.1%	+18.4%	0.338%
11/4/2024	Los Angeles Capital Management LLC	220,834	$0.44M	0.0%	-7.6%	0.146%
10/31/2024	Principal Financial Group Inc.	102,651	$0.20M	0.0%	+456.5%	0.068%
10/25/2024	Cutter & CO Brokerage Inc.	19,535	$39K	0.0%	N/A	0.013%
10/24/2024	Wealth Enhancement Advisory Services LLC	45,273	$90K	0.0%	+21.2%	0.030%
10/22/2024	Searle & CO.	86,250	$0.17M	0.0%	+684.1%	0.057%
10/16/2024	Firethorn Wealth Partners LLC	26,013	$52K	0.0%	N/A	0.017%
10/9/2024	Congress Park Capital LLC	1,978,078	$3.94M	1.5%	+25.3%	1.313%
10/3/2024	SG Americas Securities LLC	70,917	$0.14M	0.0%	-64.2%	0.047%
8/19/2024	B. Riley Wealth Advisors Inc.	11,602	$41K	0.0%	N/A	0.008%
8/16/2024	Clearline Capital LP	1,495,266	$5.23M	0.1%	-46.1%	0.993%
8/15/2024	The Manufacturers Life Insurance Company	45,771	$0.16M	0.0%	+16.0%	0.030%
8/15/2024	Millennium Management LLC	1,434,627	$5.02M	0.0%	-54.7%	0.952%
8/15/2024	AQR Capital Management LLC	607,135	$2.13M	0.0%	+1,460.9%	0.403%
8/15/2024	Caxton Associates LP	202,157	$0.71M	0.0%	N/A	0.134%
8/14/2024	Squarepoint Ops LLC	363,700	$1.27M	0.0%	+369.0%	0.241%
8/14/2024	Marshall Wace LLP	1,761,051	$6.16M	0.0%	+256.2%	1.169%
8/14/2024	Profund Advisors LLC	48,073	$0.17M	0.0%	N/A	0.032%
8/13/2024	Sei Investments Co.	12,685	$44K	0.0%	N/A	0.008%

Data available starting January 2016

See Full Table

Heron Therapeutics, Inc., a commercial-stage biotechnology company, focuses on enhancing the lives of patients by developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing ZYNRELEF, a dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam; and APONVIE, an intravenous formulation of a substance P/neurokinin-1 receptor antagonist indicated for the prevention of postoperative nausea and vomiting in adults. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in San Diego, California.

Today's Range

Now: $2.11

$2.10

$2.20

50 Day Range

MA: $2.01

$1.63

$2.55

52 Week Range

Now: $2.11

$1.04

$3.93

Volume

1,042,764 shs

Average Volume

2,362,122 shs

Market Capitalization

$321.42 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.55

Who are the company insiders with the largest holdings of Heron Therapeutics?: Heron Therapeutics' top insider shareholders include:
Adam Morgan (Director)
Craig A Collard (CEO)
Ira Duarte (CFO)
William P Forbes (EVP)
Learn More about top insider investors at Heron Therapeutics.